Transplacentar pharmacokinetics of remifentanil
Phase 1
- Conditions
- Transplacentar pharmacokinetics of Remifentanil
- Registration Number
- EUCTR2008-007972-70-BE
- Lead Sponsor
- niversity Hospital Leuven
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Pregnant females who are scheduled for a selective foeticide because of non viabel fetal disorder or intra-uterine fetal blood transfusion
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Maternal contra indication for the use of remifentanil or severe fetal asphyxia
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: to clarify the transplacentar pharmacokinetics of remifentanil during foetoscopic procedures.;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method